Abstract
It is well established that post-transplantation anemia (PTA) in renal transplant recipients (RTRs) is associated with reduced graft survival. However, there is an uncertainty of the effect of PTA on cardiovascular events and all-cause mortality. We examined prospectively in a large cohort of erythropoietin-naive patients the effects of PTA on cardiovascular morbidity, patient survival, and graft survival.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Transplantation |
Vol/bind | 27 |
Udgave nummer | 6 |
Sider (fra-til) | E636-E643 |
Antal sider | 8 |
ISSN | 0902-0063 |
DOI | |
Status | Udgivet - 3 sep. 2013 |